Effect of Lycosome-Formulated Phosphatidylcholine on Parameters of Biological Oxidation after Single Intake of Moderate Amount of Alcohol

Advances in Preventive Medicine
Ivan M PetyaevYuriy K Bashmakov

Abstract

Ingestion of a single dose of alcohol, ranging from the intake of a moderate amount alcohol to binge drinking, is the most frequent form of alcohol consumption with poorly understood medical consequences and obscure prophylactics. The study was aimed to determine whether lycosome formulated phosphatidylcholine (PC-Lyc) containing two highly bioavailable antioxidants (PC and lycopene) ingested shortly before the alcohol-containing beverage may alleviate the biochemical markers of liver damage and parameters of biological oxidation associated with the intake of a moderate amount of alcohol. Healthy middle-aged volunteers were requested to consume a moderate amount of alcohol - 0.5 ml/kg or 1.0 ml/kg shortly after ingestion of a capsule containing 450 mg of regular phosphatidylcholine (PC, n=10), PC-Lyc (n=10), or placebo pill (PP, n=10). Serum levels of ethanol (EtOH), acetaldehyde (AA), liver-specific enzymes, total antioxidant capacity of serum (TAC), oxidized LDL (LDL-Px), and malonic dialdehyde (MDA) were measured at 1, 2.5, and 5 hours after dosing with alcohol. Ingestion of PC regardless of the formulation used had no effect on serum EtOH concentration dynamics. However, volunteers supplemented with PC-Lyc showed a better c...Continue Reading

References

Jan 1, 1989·The International Journal of Biochemistry·V D AntonenkovL F Panchenko
Sep 15, 1998·Free Radical Research·K Moore, L J Roberts
May 2, 2009·Journal of Chromatographic Science·Helena PontesMaria Lourdes Bastos
Apr 22, 2011·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Jonathan Chick
Oct 30, 2012·Clinics in Liver Disease·Arthur I Cederbaum
Apr 5, 2014·ISRN Endocrinology·Yuriy K BashmakovIvan M Petyaev
May 23, 2015·Archives of Medical Science : AMS·Ivan M Petyaev
Dec 9, 2015·World Journal of Hepatology·Susana LlerenaEmilio Fábrega
Jan 26, 2016·Current Drug Metabolism·Ricardo Jorge Dinis-Oliveira
Feb 18, 2016·Oxidative Medicine and Cellular Longevity·Ivan M Petyaev
Feb 28, 2016·Gastroenterology·Laura E NagyVijay H Shah
Mar 24, 2016·International Journal of Molecular Sciences·Fang WangHua-Bin Li
May 14, 2016·Digestive Diseases·M Omar Farooq, Ramon Bataller
Jul 13, 2016·The Journal of Biological Chemistry·Max-Hinderk SchulerThomas Becker
Aug 9, 2016·Hepatobiliary & Pancreatic Diseases International : HBPD INT·Zeinab GhorbaniAzita Hekmatdoost
Oct 23, 2016·Journal of Hepatology·Felix StickelMarsha Y Morgan
Mar 10, 2017·Gut and Liver·Felix StickelRamon Bataller
Jun 14, 2017·The International Journal of Biochemistry & Cell Biology·Jennifer L Steiner, Charles H Lang
Jun 24, 2017·Pharmacology & Therapeutics·Ming-Jiang XuBin Gao
Jul 30, 2017·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Massimo Pinzani, Tu Vinh Luong
Oct 4, 2017·Journal of Clinical and Experimental Hepatology·Ajay Duseja, Shivaram P Singh
Oct 17, 2017·Frontiers in Nutrition·Ivan M Petyaev, Yuriy K Bashmakov
Nov 1, 2017·World Journal of Gastroenterology : WJG·Sukhpreet SinghKusum K Kharbanda
Jun 16, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Rongshuang YuanChunmei Wang

❮ Previous
Next ❯

Methods Mentioned

BETA
MDA

Software Mentioned

Stata SE

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.